1
|
Wang Y and Jiang T: Understanding high
grade glioma: Molecular mechanism, therapy and comprehensive
management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sathornsumetee S and Rich JN: New
treatment strategies for malignant gliomas. Expert Rev Anticancer
Ther. 6:1087–1104. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Penas-Prado M and Gilbert MR: Molecularly
targeted therapies for malignant gliomas: Advances and challenges.
Expert Rev Anticancer Ther. 7:641–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Benetatos L, Vartholomatos G and
Hatzimichael E: MEG3 imprinted gene contribution in tumorigenesis.
Int J Cancer. 129:773–779. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Guo Q, Qian Z, Yan D, Li L and Huang L:
LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by
repressing Notch signaling. Biomed Pharmacother. 82:589–594. 2016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou X, Ji G, Ke X, Gu H, Jin W and Zhang
G: MiR-141 inhibits gastric cancer proliferation by interacting
with long noncoding RNA MEG3 and down-regulating E2F3 expression.
Dig Dis Sci. 60:3271–3282. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Jiang L, Wang C, Lei F, Zhang L, Zhang X,
Liu A, Wu G, Zhu J and Song L: miR-93 promotes cell proliferation
in gliomas through activation of PI3K/Akt signaling pathway.
Oncotarget. 6:8286–8299. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Ke ZP, Xu P, Shi Y and Gao AM: MicroRNA-93
inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by
targeting PTEN. Oncotarget. 7:28796–28805. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Schildge S, Bohrer C, Beck K and
Schachtrup C: Isolation and culture of mouse cortical astrocytes. J
Vis Exp. 71:pii: 50079. 2013.
|
20
|
Slezak M, Korostynski M, Gieryk A, Golda
S, Dzbek J, Piechota M, Wlazlo E, Bilecki W and Przewlocki R:
Astrocytes are a neural target of morphine action via
glucocorticoid receptor-dependent signaling. Glia. 61:623–635.
2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Pongrac IM, Dobrivojević M, Ahmed LB,
Babič M, Šlouf M, Horák D and Gajović S: Improved biocompatibility
and efficient labeling of neural stem cells with
poly(L-lysine)-coated maghemite nanoparticles. Beilstein J
Nanotechnol. 7:926–936. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang W, Shi W and Li H: A modified in
vitro method to obtain pure astrocyte cultures induced from mouse
hippocampal neural stem cells using clonal expansion. Cell Mol
Neurobiol. 32:373–380. 2012. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yu C, Wang M, Li Z, Xiao J, Peng F, Guo X,
Deng Y, Jiang J and Sun C: MicroRNA-138-5p regulates pancreatic
cancer cell growth through targeting FOXC1. Cell Oncol (Dordr).
38:173–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu J, Ma L, Li C, Zhang Z, Yang G and
Zhang W: Tumor-targeting TRAIL expression mediated by miRNA
response elements suppressed growth of uveal melanoma cells. Mol
Oncol. 7:1043–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Li R, Chen X, You Y, Wang X, Liu Y, Hu Q
and Yan W: Comprehensive portrait of recurrent glioblastoma
multiforme in molecular and clinical characteristics. Oncotarget.
6:30968–30974. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Cuddapah VA, Robel S, Watkins S and
Sontheimer H: A neurocentric perspective on glioma invasion. Nat
Rev Neurosci. 15:455–465. 2014. View
Article : Google Scholar : PubMed/NCBI
|
28
|
Wang L, Chen Q, Chen Z, Tian D, Xu H, Cai
Q, Liu B and Deng G: EFEMP2 is upregulated in gliomas and promotes
glioma cell proliferation and invasion. Int J Clin Exp Pathol.
8:10385–10393. 2015.PubMed/NCBI
|
29
|
Di K, Linskey ME and Bota DA: TRIM11 is
overexpressed in high-grade gliomas and promotes proliferation,
invasion, migration and glial tumor growth. Oncogene. 32:5038–5047.
2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Peng W, Si S, Zhang Q, Li C, Zhao F, Wang
F, Yu J and Ma R: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate gastric cancer progression. J Exp Clin
Cancer Res. 34:792015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Luo G, Wang M, Wu X, Tao D, Xiao X, Wang
L, Min F, Zeng F and Jiang G: Long non-coding RNA MEG3 inhibits
cell proliferation and induces apoptosis in prostate cancer. Cell
Physiol Biochem. 37:2209–2220. 2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ying L, Huang Y, Chen H, Wang Y, Xia L,
Chen Y, Liu Y and Qiu F: Downregulated MEG3 activates autophagy and
increases cell proliferation in bladder cancer. Mol Biosyst.
9:407–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH
and Guo RH: Decreased expression of long noncoding RNA MEG3 affects
cell proliferation and predicts a poor prognosis in patients with
colorectal cancer. Tumour Biol. 36:4851–4859. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Leucci E, Patella F, Waage J, Holmstrøm K,
Lindow M, Porse B, Kauppinen S and Lund AH: microRNA-9 targets the
long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep.
3:25352013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of BCL2 and the
nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci. 105:265–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
39
|
Tian Y, Nan Y, Han L, Zhang A, Wang G, Jia
Z, Hao J, Pu P, Zhong Y and Kang C: MicroRNA miR-451 downregulates
the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol.
40:1105–1112. 2012.PubMed/NCBI
|
40
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
41
|
Fabbri E, Brognara E, Montagner G,
Ghimenton C, Eccher A, Cantù C, Khalil S, Bezzerri V, Provezza L,
Bianchi N, et al: Regulation of IL-8 gene expression in gliomas by
microRNA miR-93. BMC Cancer. 15:6612015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Xu C, Sun G, Yuan G, Wang R and Sun X:
Effects of platycodin D on proliferation, apoptosis and PI3K/Akt
signal pathway of human glioma U251 cells. Molecules.
19:21411–21423. 2014. View Article : Google Scholar : PubMed/NCBI
|
43
|
Chang Y, Wu Q, Tian T, Li L, Guo X, Feng
Z, Zhou J, Zhang L, Zhou S, Feng G, et al: The influence of SRPK1
on glioma apoptosis, metastasis, and angiogenesis through the
PI3K/Akt signaling pathway under normoxia. Tumour Biol.
36:6083–6093. 2015. View Article : Google Scholar : PubMed/NCBI
|
44
|
Ribarska T, Goering W, Droop J, Bastian
KM, Ingenwerth M and Schulz WA: Deregulation of an imprinted gene
network in prostate cancer. Epigenetics. 9:704–717. 2014.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Chunharojrith P, Nakayama Y, Jiang X, Kery
RE, Ma J, De La Hoz Ulloa CS, Zhang X, Zhou Y and Klibanski A:
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived
cell line. Mol Cell Endocrinol. 416:27–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
46
|
Hu D, Su C, Jiang M, Shen Y, Shi A, Zhao
F, Chen R, Shen Z, Bao J and Tang W: Fenofibrate inhibited
pancreatic cancer cells proliferation via activation of p53
mediated by upregulation of LncRNA MEG3. Biochem Biophys Res
Commun. 471:290–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
47
|
Li J, Bian EB, He XJ, Ma CC, Zong G, Wang
HL and Zhao B: Epigenetic repression of long non-coding RNA MEG3
mediated by DNMT1 represses the p53 pathway in gliomas. Int J
Oncol. 48:723–733. 2016.PubMed/NCBI
|